| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 30.821 | 32.600 | 45.761 | 58.125 | 55.060 | 57.684 | 75.269 | 76.602 | 78.354 | 77.410 |
| Total Income - EUR | 30.821 | 32.600 | 45.766 | 58.125 | 55.060 | 57.685 | 75.270 | 76.602 | 78.356 | 77.412 |
| Total Expenses - EUR | 12.911 | 11.542 | 10.811 | 11.521 | 11.801 | 12.704 | 13.621 | 14.971 | 17.284 | 57.114 |
| Gross Profit/Loss - EUR | 17.910 | 21.058 | 34.955 | 46.604 | 43.260 | 44.981 | 61.649 | 61.631 | 61.071 | 20.298 |
| Net Profit/Loss - EUR | 16.986 | 20.406 | 34.497 | 46.023 | 42.709 | 44.648 | 60.987 | 60.881 | 60.405 | 18.022 |
| Employees | 6 | 5 | 4 | 5 | 4 | 4 | 4 | 4 | 1 | 2 |
Check the financial reports for the company - Respimax Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 599 | 1.743 | 1.341 | 1.112 | 901 | 698 | 500 | 319 | 136 | 1.226 |
| Current Assets | 27.603 | 19.256 | 33.926 | 45.800 | 43.163 | 50.103 | 62.230 | 61.776 | 74.947 | 18.421 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.165 | 3.636 | 3.073 | 4.713 | 33.219 | 41.701 | 46.032 | 45.255 | 47.340 | 4.455 |
| Cash | 25.437 | 15.620 | 30.853 | 41.087 | 9.944 | 8.402 | 16.199 | 16.521 | 27.607 | 13.966 |
| Shareholders Funds | 27.639 | 20.459 | 34.550 | 46.093 | 42.813 | 44.697 | 61.053 | 60.929 | 60.501 | 18.076 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 562 | 540 | 718 | 819 | 1.251 | 6.103 | 1.677 | 1.166 | 14.583 | 1.571 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Respimax Srl